Clinical Trials
257
Active:17
Completed:118
Trial Phases
6 Phases
Early Phase 1:6
Phase 1:26
Phase 2:32
+3 more phases
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (217 trials with phase data)• Click on a phase to view related trials
Not Applicable
84 (38.7%)Phase 3
43 (19.8%)Phase 2
32 (14.7%)Phase 1
26 (12.0%)Phase 4
26 (12.0%)Early Phase 1
6 (2.8%)Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.
Phase 3
Not yet recruiting
- Conditions
- Hepatocellular Carcinoma (HCC)
- Interventions
- Drug: Chemotherapy/Radiation
- First Posted Date
- 2025-06-18
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 30
- Registration Number
- NCT07027436
- Locations
- 🇨🇦
Juravinski Hospital, Hamilton, Ontario, Canada
Intravascular Ultrasound for Peripheral Artery Disease Revascularization
Not Applicable
Not yet recruiting
- Conditions
- Peripheral Arterial Disease(PAD)Chronic Limb Threatening IschemiaIntravascular UltrasoundMajor Adverse Limb EventsRestenosis
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 772
- Registration Number
- NCT06979284
Health Literacy in Geriatric Patients
Recruiting
- Conditions
- Health Literacy
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT06971393
- Locations
- 🇨🇦
St. Peter's Geriatric Clinic, Hamilton, Ontario, Canada
Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
- First Posted Date
- 2025-04-03
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT06908694
- Locations
- 🇨🇦
Juravinski Cancer Centre, Hamilton, Ontario, Canada
SCORE! ACTIVE Trial
Not Applicable
Recruiting
- Conditions
- Chronic DiseaseChildhood Obesity
- First Posted Date
- 2025-02-25
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 1400
- Registration Number
- NCT06844786
- Locations
- 🇨🇦
McMaster University, Hamilton, Ontario, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 48
- Next
News
No news found